T 0492/24 (STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE FOR NASAL ADMINISTRATION/Glenmark Speciality S.A.) of 16.01.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T049224.20260116
- Date of decision
- 16 January 2026
- Case number
- T 0492/24
- Online on
- 20 March 2026
- Petition for review of
- -
- Application number
- 14781946.0
- IPC class
- A61K 31/58A61K 9/10A61K 31/335
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE FOR NASAL ADMINISTRATION
- Applicant name
- Glenmark Specialty S.A.
- Opponent name
- Ter Meer Steinmeister & Partner Patentanwälte mbB
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Main request and auxiliary request 1 - Amendments (No)
Auxiliary request 3 - Amendments (Yes)
Admission of new documents
Auxiliary request 3 - Inventive step (Yes) - Catchword
- -
- Cited cases
- T 1556/16
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of claims 1 to 14 of auxiliary request 3 filed with the reply to the statement of grounds of appeal and a description to be adapted thereto, if necessary.